InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,660.80
(
0.11%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
-1.63%
)
Bitcoin
60,753.73
(
-3.64%
)
Post# of 672
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

realfast95

Send PM Follow Ignore
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

realfast95

Re: None

Monday, 01/09/2017 8:55:48 PM

Monday, January 09, 2017 8:55:48 PM

Post# of 672
FDA screw-over on the Nasal. Exclusivity shows up in November 2016, for a product not even available. Yet EGLT also has a nasal product, which means the other company didn't deserve it. Even the analyst didn't know about it.

IMO the FDA is on the take!

The only abuse deterrent IMO, is making the patient go to a clinic to receive it each time.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up